Transcobalamin Receptor Peptides for the Treatment of Cancer
A novel class of drugs for treating various cancers and Vitamin B12 deficiency.
Background:
Cancer is a leading cause of mortality, resulting in over 8 million deaths worldwide. Furthermore, the incidence is expected to rise by more than 50% over the next 15 years to 22 million patients and accounts for over $156 billion in yearly healthcare costs....
Published: 5/13/2025
|
Inventor(s): Edward Quadros, Jeffrey Sequeira
Keywords(s): Technologies
Category(s): Campus > SUNY Downstate Health Sciences University, Technology Classifications, Technology Classifications > Therapeutics and Vaccines
|